Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle

Brooks, S. & Faulkner, J. Contractile properties of skeletal muscles from young, adult and aged mice. J. Physiol. 404, 71–82 (1988).

Musaro, A. et al. Enhanced expression of myogenic regulatory factors in aging skeletal muscle. Exp. Cell Res. 221, 241–248 (1995).

Nelson, K. The cancer anorexia-cachexia syndrome. Semin. Oncol. 27, 64–68 (2000).

Florini, J., Ewton, D. & Coolican, S. Growth hormone and the insulin-like growth factor system in myogenesis. Endocrine Rev. 17, 481–517 (1996).

Stewart, C. & Rotwein, P. Growth, differentation, and survival: multiple physiological functions for insulin-like growth factors. Physiol. Rev. 76, 1005–1026 (1996).

Sjogren, K. et al. Liver-derived IGF-1 is the principal source of IGF-1 in blood but is not required for postnatal body growth in mice. Proc. Natl. Acad. Sci. USA 96, 7088–7092 (1999).

Rosenthal, S. & Cheng, Z.Q. Opposing early and late effects of insulin-like growth factor I on differentiation and the cell cycle regulatory retinoblastoma protein in skeletal myoblasts. Proc. Natl. Acad. Sci. USA 92, 10307–10311 (1995).

Engert, J., Berglund, E.B. & Rosenthal, N. Proliferation precedes differentiation in IGF-1 stimulated myogenesis. J. Cell Biol. 135, 431–440 (1996).

Mathews, L. et al. Growth enhancement of transgenic mice expressing human insulin-like growth factor-I. Endocrinology 123, 2827–2833 (1988).

Coleman, M. et al. Myogenic vector expression of insulin-like growth factor I stimulate myocyte differentiation and myofiber hypertrophy in transgenic mice. J. Biol. Chem. 270, 12109–12116 (1995).

Reiss, K. et al. Overexpression of insulin-like growth factor-I in the heart is coupled with myocyte proliferation in transgenic mice. Proc. Natl. Acad. Sci. USA 93, 8630–8635 (1996).

Delaughter, M.C., Taffet, G.E., Fiorotto, M.L., Entman, M.L. & Schwartz, R.J. Local insulin-like growth factor I expression induces physiologic, then pathologic cardiac hypertrophy in transgenic mice. FASEB J. 13, 1923–1929 (1999).

Adamo, M. et al. Structure, expression and regulation of the IGF-1 gene. Adv. Exp. Med. Biol. 343, 1–11 (1993).

Grieshammer, U., Sassoon, D. & Rosenthal, N. A transgene target for positional regulators marks early rostrocaudal specification of myogenic lineages. Cell 69, 79–93 (1992).

Musaro, A. & Rosenthal, N. Maturation of the myogenic program is induced by post-mitotic expression of IGF-1. Mol. Cell. Biol. 19, 3115–3124 (1999).

Musaro, A., McKullagh, K.J.A., Naya, F.J., Olson, E.N. & Rosenthal, N. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in assocation with GATA-2 and NF-ATc1. Nature 400, 581–585 (1999).

Semsarian, C. et al. Skeletal muscle hypertrophy is mediated by a Ca2+-dependent calcineurin signalling pathway. Nature 400, 576–581 (1999).

Molkentin, J. et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93, 215–228 (1998).

Lim, H. et al. Reversal of cardiac hypertrophy in transgenic disease models by calcineurin inhibition. J. Mol. Cell. Cardiol. 32, 697–709 (2000).

Chin, E. et al. A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev. 12, 2499–2509 (1998).

Naya, F. et al. Stimulation of slow skeletal muscle fiber gene expression by calcineurin in vivo. J. Biol. Chem. 275, 4545–4548 (2000).

Bigard, X. et al. Calcineurin co-regulates contractile and metabolic components of slow muscle phenotype. J. Biol. Chem. 275, 19653–19660 (2000).

Abbott, K.L., Friday, B.B., Thaloor, D., Murphy, T.J. & Pavlath, G.K. Activation and cellular localization of the cyclosporine A-sensitive transcription factor NF-AT in skeletal muscle cells. Mol. Biol. Cell 9, 2905–2916 (1998).

Passier, R. et al. CaM kinase singaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. J. Clin. Invest. 105, 1395–1406 (2000).

Lescaudron, L., Creuzet, S.E., Li, Z., Paulin, D. & Fontaine-Perus, J. Desmin-lacZ transgene expression and regeneration within skeletal muscle transplants. J. Muscle Res. Cell. Motil. 18, 631–641 (1997).

Barton-Davis, E., Shoturma, D.I., Musaro, A., Rosenthal, N. & Sweeney, H.L. Viral mediated expression of IGF-1 blocks the aging-related loss of skeletal muscle function. Proc. Natl. Acad. Sci. USA 95, 15603–15607 (1998).

Barton-Davis, E.R., Shoturma, D.I. & Sweeney, H.L. Contribution of satellite cells to IGF-1 induced hypertrophy of skeletal muscle. Acta Physiol. Scand. 167, 301–305 (1999).

LeRoith, D. & Roberts, C.T., Jr. At the cutting edge. Insulin-like growth factor I (IGF-1): a molecular basis for endocrine versus local action. Mol. Cell. Endocrinol. 77, C57–C61 (1991).

McKoy, G. et al. Expression of insulin growth factor-I splice variants and structural genes in rabbit skeletal muscle induced by stretch and stimulation. J. Physiol. 516, 583–592 (1999).